{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:51:28Z","timestamp":1777477888958,"version":"3.51.4"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["24K09955"],"award-info":[{"award-number":["24K09955"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The administration of eltrombopag, used to restore low blood count, demonstrates a positive interference of blood bilirubin levels when analyzed through the diazo assay. However, research on bilirubin measurements using other methods is limited. Therefore, using an enzymatic assay, this study aimed to investigate the effect of serum eltrombopag on bilirubin measurements in patients with aplastic anemia. It further assessed the concentration-dependent effect of eltrombopag on bilirubin measurements using enzymatic and vanadate oxidation assays.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Total and conjugated bilirubin concentrations measured using an enzymatic assay and serum eltrombopag concentrations were examined in 227 serum samples collected from 30 patients with aplastic anemia receiving eltrombopag. Eltrombopag-spiked samples were analyzed using the enzymatic and vanadate oxidation assays for total and conjugated bilirubin to determine its concentration-dependent effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A strong positive correlation was observed between total bilirubin and serum eltrombopag concentrations in patients receiving eltrombopag (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.820). However, the correlation between conjugated bilirubin and serum eltrombopag concentrations was weaker (<jats:italic toggle=\"yes\">r<\/jats:italic> = 0.413). In eltrombopag-spiked serum samples, the enzymatic assay showed significant false elevation of total bilirubin concentrations at \u22656.0 mcg\/mL; no interference with conjugated bilirubin measurements was observed. The vanadate oxidation assay showed mild positive biases of 0.2 and 0.1 mg\/dL for total and conjugated bilirubin concentrations, respectively, at a high eltrombopag concentration (50 mcg\/mL).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Eltrombopag causes clinically significant concentration-dependent interference in total blood bilirubin, but not in conjugated bilirubin measurements through the enzymatic assay in patients with aplastic anemia. The vanadate oxidation assay may be used as an alternative to measure total blood bilirubin when the eltrombopag concentration is below 50 mcg\/mL.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001307","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T15:00:10Z","timestamp":1738767610000},"page":"635-640","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Eltrombopag-Induced Falsely Elevated Bilirubin Concentrations in Enzymatic and Vanadate Oxidation Assays: Involvement of High Serum Eltrombopag Concentrations"],"prefix":"10.1097","volume":"47","author":[{"given":"Shun","family":"Oda","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan;"},{"name":"Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Doki","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan;"},{"name":"Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoshi","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiharu","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Hematology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan;"},{"name":"Laboratory of Stem Cell Therapy, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan; and"},{"name":"Department of Hematology, Mito Saiseikai General Hospital, Mito, Ibaraki, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Homma","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki, Japan;"},{"name":"Department of Pharmacy, University of Tsukuba Hospital, Tsukuba, Ibaraki, Japan;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"R1-20250912","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa073275","article-title":"Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura","volume":"357","author":"Bussel","year":"2007","journal-title":"N Engl J Med"},{"key":"R2-20250912","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1200931","article-title":"Eltrombopag and improved hematopoiesis in refractory aplastic anemia","volume":"367","author":"Olnes","year":"2012","journal-title":"N Engl J Med"},{"key":"R3-20250912","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cpt.2918","article-title":"Safety profile of eltrombopag in different age groups: an analysis of real-world pharmacovigilance and randomized clinical trials","volume":"114","author":"Qu","year":"2023","journal-title":"Clin Pharmacol Ther"},{"key":"R5-20250912","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1182\/blood-2017-04-748707","article-title":"Safety and efficacy of long-term treatment of chronic\/persistent ITP with eltrombopag: final results of the EXTEND study","volume":"130","author":"Wong","year":"2017","journal-title":"Blood"},{"key":"R6-20250912","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1182\/blood.2021012130","article-title":"Long-term outcomes in patients with severe aplastic anemia treated with immunosuppression and eltrombopag: a phase 2 study","volume":"139","author":"Patel","year":"2022","journal-title":"Blood"},{"key":"R7-20250912","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0021-9258(18)74392-5","article-title":"The determination of bilirubin with the photoelectric colorimeter","volume":"119","author":"Malloy","year":"1937","journal-title":"J Biol Chem"},{"key":"R8-20250912","first-page":"116","article-title":"A new method of measuring bilirubin in serum by vanadic acid","volume":"22","author":"Tokuda","year":"1993","journal-title":"Jpn J Clin Chem"},{"key":"R9-20250912","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0009-9120(88)80109-7","article-title":"A new enzymatic approach for estimating total and direct bilirubin","volume":"21","author":"Otsuji","year":"1988","journal-title":"Clin Biochem"},{"key":"R10-20250912","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.plabm.2017.05.004","article-title":"Operational impact of using a vanadate oxidase method for direct bilirubin measurements at an academic medical center clinical laboratory","volume":"8","author":"Dhungana","year":"2017","journal-title":"Pract Lab Med"},{"key":"R11-20250912","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5858\/arpa.2015-0473-LE","article-title":"Eltrombopag: investigation of previously reported serum discoloration and negative interference on a total bilirubin diazo method","volume":"140","author":"Adams","year":"2016","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250912","doi-asserted-by":"crossref","first-page":"e23796","DOI":"10.1002\/jcla.23796","article-title":"Interference of eltrombopag with bilirubin measurements on the Vitros 5600 analyzer","volume":"35","author":"Poventud-Fuentes","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"R13-20250912","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1515\/cclm-2019-0684","article-title":"Comprehensive characterization and resolution of discrepant spectrophotometric bilirubin results in patients on eltrombopag therapy","volume":"58","author":"Cheng","year":"2020","journal-title":"Clin Chem Lab Med"},{"key":"R14-20250912","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcp\/aqac139","article-title":"Use of a vanadate oxidation conjugated bilirubin assay to reduce test cancellations resulting from hemolyzed specimens in pediatric patients","volume":"159","author":"Kaumeyer","year":"2023","journal-title":"Am J Clin Pathol"},{"key":"R15-20250912","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-8981(97)00194-0","article-title":"A new enzymatic assay for selectively measuring conjugated bilirubin concentration in serum with use of bilirubin oxidase","volume":"269","author":"Kurosaka","year":"1998","journal-title":"Clin Chim Acta"},{"key":"R16-20250912","doi-asserted-by":"crossref","first-page":"772873","DOI":"10.3389\/fphar.2021.772873","article-title":"Pharmacokinetic evaluation of eltrombopag in ITP pediatric patients","volume":"12","author":"Dionisi","year":"2021","journal-title":"Front Pharmacol"},{"key":"R17-20250912","doi-asserted-by":"crossref","first-page":"e5049","DOI":"10.1002\/bmc.5049","article-title":"A simple HPLC assay for determining eltrombopag concentration in human serum","volume":"35","author":"Yanagimachi","year":"2021","journal-title":"Biomed Chromatogr"},{"key":"R18-20250912","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1038\/s41598-017-01602-w","article-title":"Biliverdin reductase inhibitors did not improve severe unconjugated hyperbilirubinemia in vivo","volume":"7","author":"van Dijk","year":"2017","journal-title":"Sci Rep"},{"key":"R19-20250912","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/s10953-017-0682-z","article-title":"Overlapping pK a of the multiprotic hemostyptic eltrombopag using UV\u2013Vis multiwavelength spectroscopy and potentiometry","volume":"46","author":"Meloun","year":"2017","journal-title":"J Solution Chem"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001307","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T12:02:24Z","timestamp":1757678544000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000001307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001307","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"2024-10-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-12-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}